Scenarios that move BMRN
BioMarin Pharmaceutical Inc. - Common Stock
Scenarios that move BMRN: 4 analyses, 2 positive, 2 negative.
- · Ascendis Pharma receives positive CHMP opinion for TransCon CNP — ▼ · impact -59 · confidence medium · horizon weeks
- · RARE's Fayuvi approval triggers second $203 million PRV sale — ▲ · impact +42 · confidence low · horizon quarters
- · Mirum's Brelovitug meets goal in Phase III AZURE-1 study — ▲ · impact +22 · confidence low · horizon weeks
- · Ascendis announces planned $400 million share repurchase program — ▼ · impact -34 · confidence low · horizon quarters